Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 3 open reading frame 20 (C3orf20)
- Target
- C3orf20
- Molecular classification
- Other (Uncharacterized protein)
01
Overview
C3orf20 (chromosome 3 open reading frame 20) encodes an **uncharacterized cytoplasmic protein**[4]. Its exact biological roles remain unknown, but one studied SNP (rs12496846) in its intronic region is associated with inter-individual differences in opioid analgesic requirement, possibly by modulating C3orf20 gene expression in the brain and testes[3]. The gene is broadly expressed in tissues such as testis, bone marrow, and brain, but its protein product has not been structurally or functionally characterized in detail[3][4]. C3orf20 is not currently categorized as a therapeutic target and is not associated directly with any disease or therapy but may be of future pharmacogenomic interest as a biomarker for opioid sensitivity[3][4].
- Other names
- C3orf20Uncharacterized protein C3orf20DKFZP434N1817
02
Mechanism of action
None. There is no evidence of a mechanism of action for drugs targeting this molecule, as no drugs are known to interact with it.
03
Biological functions
Unknown. At present, the specific biological function of C3orf20 is not determined or annotated in major resources. One study links genetic variation in C3orf20 to differences in mRNA expression and suggests a possible role in individual differences in opioid analgesia requirement, but the mechanism remains undetermined.
04
Disease associations
Other (Possible pharmacogenomic relevance). Some evidence suggests that a single-nucleotide polymorphism (SNP) in C3orf20 (rs12496846) may affect postoperative opioid analgesic requirements, indicating a potential role as a *biomarker for analgesic sensitivity* but not as a direct disease mediator.
05
Biomarkers
rs12496846 SNP in C3orf20 is suggested as a possible pharmacogenomic biomarker for predicting individual opioid analgesic requirements after surgery
Beyond the preview
Go deeper on Chromosome 3 open reading frame 20 (C3orf20).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chromosome 3 open reading frame 20 (C3orf20).